Social Media Use Motives and Mental Health Among Adolescents: Cross-Sectional Study
JMIR Mental Health · 2026-10-28 · 13 · e111020-e111020
DOI: 10.2196/111020 ↗Abstract
Abstract Background Social media use is ubiquitous among young people, yet its relationship with mental health may depend on why it is used. Understanding the motives underlying social media engagement may provide greater insights into its potential risks and benefits than considering overall use alone. Objective This study aimed to identify latent dimensions of motives for social media use and examine their associations with anxiety, depression, well-being, and resilience in a sample of older adolescents. Methods Cross-sectional data were drawn from the BrainWaves study (N=6820; mean age 16.72, SD 0.74 years). Social media use motives were assessed using 10 items and exploratory factor analysis identified 2 latent dimensions: avoidant-escapist use (boredom, addiction, distraction, and procrastination) and social-recreational use (socializing, communication, entertainment, and observation). Confirmatory factor analysis was used to estimate factor scores, which were examined using linear regression. Structural equation modeling estimated associations with anxiety, depression, well-being, and resilience, with secondary analyses accounting for gender and deprivation. Results Linear regression analyses showed that avoidant-escapist motives were associated with higher anxiety and depressive symptoms, whereas social-recreational motives were associated with lower symptoms. No interactions with gender or deprivation were observed. The structural equation model showed acceptable model fit (comparative fit index=0.945; root mean squared error of approximation=0.057; standardized root mean squared residual=0.054). Avoidant-escapist motives were associated with higher anxiety (β=0.543) and depressive symptoms (β=0.629) and lower well-being (β=−0.610) and resilience (β=−0.469). Conversely, social-recreational motives were associated with lower anxiety (β=−0.228) and depressive symptoms (β=−0.342) and higher well-being (β=0.362) and resilience (β=0.242; P
EUVIMED